References
- Amato, P., et al., 2014. Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. Fertility and sterility, 101 (1), 31–35. doi:10.1016/j.fertnstert.2013.11.030
- Appleby, J.B., 2015. The ethical challenges of the clinical introduction of mitochondrial replacement techniques. Medicine, health care and philosophy, 18 (4), 501–514. doi:10.1007/s11019-015-9656-3
- Baylis, F., 2013. The ethics of creating children with three genetic parents. Reproductive biomedicine online, 26 (6), 531–534. doi:10.1016/j.rbmo.2013.03.006
- Capalbo, A., et al., 2017. Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization Cycles. Fertility and Sterility, 108 (6), 1007–1015.e3. doi:10.1016/j.fertnstert.2017.08.004
- Castro, R.J., 2016. Mitochondrial replacement therapy: the UK and US regulatory landscapes. Journal of Law and the Biosciences, 3 (3), 726–735. doi:10.1093/jlb/lsw051
- Centers for Disease Control and Prevention, 2020. Genetic counseling, genomics & precision health. Centers for Disease Control and Prevention.
- Cleveland Clinic, 2018. Mitochondrial diseases. Cleveland Clinic.
- Craven, L., et al., 2018. Scientific and ethical issues in mitochondrial donation. The New Bioethics, 24 (1), 57–73. doi:10.1080/20502877.2018.1440725
- Department of Health (United Kingdom), 2008. Human Fertilisation and Embryology Act 2008. The National Archives.
- Dimond, R., 2015. Social and ethical issues in mitochondrial donation. British medical bulletin, 115 (1), 173–182. doi:10.1093/bmb/ldv037
- Genetic and Rare Diseases Information Center, 2013. Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes. National Institutes of Health.
- Genetics Home Reference, 2017. Mitochondrial DNA: your guide to understanding. U.S. National Library of Medicine. Available from https://ghr.nlm.nih.gov/mitochondrial-dna#idiogram
- Gómez-Tatay, L., Hernández-Andreu, J., and Aznar, J., 2017. Mitochondrial modification techniques and ethical issues. Journal of clinical medicine, 6 (3), 25. doi:10.3390/jcm6030025
- Heijkoop, M., Semon Dubas, J., and Van Aken, M.A.G., 2009. Parent-child resemblance and kin investment: physical resemblance or personality similarity? European journal of developmental psychology, 6 (1), 64–69. doi:10.1080/17405620802642306
- Ishii, T., 2018. Reproductive medicine involving mitochondrial DNA modification: evolution, legality, and ethics. EMJ repro health, 4, 88–99.
- Ma, H., et al., 2016. Incompatibility between nuclear and mitochondrial genomes contributes to an interspecies reproductive barrier. Cell Metabolism, 24 (2), 283–294. doi:10.1016/j.cmet.2016.06.012
- Martin, J.A., et al., 2019. National vital statistics reports births : final data for 2018. Centers for disease control and prevention, 68 (13), 1–104.
- Mitalipov, S. and Wolf, D.P., 2014. Clinical and ethical implications of mitochondrial gene Transfer. Trends in endocrinology and metabolism, 25 (1), 5–7. doi:10.1016/j.tem.2013.09.001
- National Academies of Sciences Engineering and Medicine, 2016. Mitochondrial replacement techniques: ethical, social, and policy considerations. A. Claiborne, R. English, and J. Kahn, eds. Washington, DC: The National Academies Press. doi:10.17226/21871
- Palacios-González, C., 2017. Are there moral differences between maternal spindle transfer and pronuclear transfer? Medicine, health care and philosophy, 20 (4), 503–511. doi:10.1007/s11019-017-9772-3
- Pompei, M. and Pompei, F., 2019. Overcoming bioethical, legal, and hereditary barriers to mitochondrial replacement therapy in the USA. Journal of assisted reproduction and genetics, 36 (3), 383–393. doi:10.1007/s10815-018-1370-7
- Public Health Directorate/Health Science and Bioethics Division, 2014. Mitochondrial donation: government response to the consultation on draft regulations to permit the use of new treatment techniques to prevent the transmission of a serious mitochondrial disease from mother to child. Department of health. doi:10.12968/bjom.2015.23.4.236
- Rai, P.K., et al., 2018. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome. Essays in biochemistry, 62 (3), 455–465. doi:10.1042/ebc20170113
- Reznichenko, A.S., Huyser, C., and Pepper, M.S., 2016. Mitochondrial transfer: implications for assisted reproductive technologies. Applied and translational genomics, 11, 40–47. doi:10.1016/j.atg.2016.10.001
- Saxena, N., et al., 2018. Mitochondrial donation: a boon or curse for the treatment of incurable mitochondrial diseases. Journal of human reproductive sciences, 11, 365. doi:10.4103/jhrs.JHRS_54_17
- Tachibana, M., Kuno, T., and Yaegashi, N., 2018. Mitochondrial replacement therapy and assisted reproductive technology: a paradigm shift toward treatment of genetic diseases in gametes or in early embryos. Reproductive medicine and biology, 17 (4), 421–433. doi:10.1002/rmb2.12230
- United Mitochondrial Disease Foundation, 2020. Understanding & navigating mitochondrial disease. Pittsburgh, PA: United Mitochondrial Disease Foundation.
- Wang, J. and Sauer, M.V., 2006. In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement. Therapeutics and clinical risk management, 2 (4), 355–364. doi:10.2147/tcrm.2006.2.4.355
- Watts, G., et al., 2012. Novel techniques for the prevention of mitochondrial DNA disorders. London, England: Nuffield Council on Bioethics.